GSDMB and pancreatic adenocarcinoma: Methylation analysis showed that promoter methylation negatively correlated with GSDMB expression level in KIRC (p < 0.001), uterine corpus endometrial carcinoma (UCEC) (p < 0.01), lung adenocarcinoma (LUAD) (p < 0.001), and pancreatic adenocarcinoma (PAAD) (p < 0.001) (Figures 2A–D).